FASLG and graft versus host disease: Fas-L levels were lower in the GVHD group than in the non-GVHD group (20.52 ± 19.82 vs. 54.74 ± 60.64, p = 0.002) but increased compared to the DED group (4.38 ± 7.66, p < 0.001).